- Lobbying
- Lobbying by Harmony Biosciences, LLC
Lobbying Relationship
Bills mentioned
H.R.3: Elijah E. Cummings Lower Drug Costs Now Act
Sponsor: Frank Pallone (D-N.J.)
H.R.6000: Cures 2.0 Act
Sponsor: Diana DeGette (D-Colo.)
H.R.5585: ARPA–H Act
Sponsor: Anna G. Eshoo (D-Calif.)
H.R.6963: Accelerated Approval Integrity Act of 2022
Sponsor: Frank Pallone (D-N.J.)
H.R.2623: Cameron’s Law
Sponsor: Josh Gottheimer (D-N.J.)
H.R.7667: Food and Drug Amendments of 2022
Sponsor: Anna G. Eshoo (D-Calif.)
S.4348: FDASLA Act of 2022
Sponsor: Patty Murray (D-Wash.)
H.R.6833: Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Sponsor: Angie Craig (D-Minn.)
H.R.8641: Orphan Drug COVID–19 Mitigation Act of 2022
Sponsor: Josh Gottheimer (D-N.J.)
H.R.1730: Speeding Therapy Access Today Act of 2021
Sponsor: Gus Bilirakis (R-Fla.)
S.670: Speeding Therapy Access Today Act of 2021
Sponsor: Amy Klobuchar (D-Minn.)
H.R.5376: Inflation Reduction Act of 2022
Sponsor: John Yarmuth (D-Ky.)
H.R.1350: Cameron’s Law
Sponsor: Josh Gottheimer (D-N.J.)
H.R.1805: Leo’s Law
Sponsor: Josh Gottheimer (D-N.J.)
H.R.2673: American Innovation and R&D Competitiveness Act of 2023
Sponsor: Ron Estes (R-Kansas)
H.R.830: Help Ensure Lower Patient Copays Act
Sponsor: Buddy Carter (R-Ga.)
S.1375: HELP Copays Act
Sponsor: Roger Marshall (R-Kan.)
H.R.5539: Optimizing Research Progress Hope And New Cures Act
Sponsor: John Joyce (R-Pa.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Keith Studdard | Legislative Director, Rep. Marsha Blackburn |
John Ray | Legislative Assistant, Rep. Mike Kelly |
John Herzog | Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President |
Kelsey Carlson | Special Assistant, National Security Council; Special Assistant, International Trade Administration, Dept of Commerce; Policy Advisor, Office of the Deputy Chief of Staff, Executive Office of the President; Confidential Assistant, Dept of Commerce |
Jeffrey Kimbell | n/a |
Jodie Lockhart | n/a |
Kenneth Hodge | n/a |
David Rudloff | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Office of Natl Drug Control Policy (NDCP)
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate